Answer
Dacomitinib targets abnormal EGFR signalling, so a validated test is needed to confirm that the tumour carries a mutation likely to respond.
Sources for this answer
- Vizimpro 45 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.